Zhu, H., Yang, X., Ding, Y., Liu, J., Lu, J., Zhan, L., . . . Sun, X. (2015). Recombinant human endostatin enhances the radioresponse in esophageal squamous cell carcinoma by normalizing tumor vasculature and reducing hypoxia. Sci Rep.
Chicago Style CitationZhu, Hongcheng, et al. "Recombinant Human Endostatin Enhances the Radioresponse in Esophageal Squamous Cell Carcinoma By Normalizing Tumor Vasculature and Reducing Hypoxia." Sci Rep 2015.
Cita MLAZhu, Hongcheng, et al. "Recombinant Human Endostatin Enhances the Radioresponse in Esophageal Squamous Cell Carcinoma By Normalizing Tumor Vasculature and Reducing Hypoxia." Sci Rep 2015.
Atenció: Aquestes cites poden no estar 100% correctes.